CDMO250117C17500
- 0.46
- 0.000.00%
Avid Bioservices Newsroom
Havencrest Homecare Platform, Avid Health at Home, Announces Additional Acquisition in North Carolina
Press Release: Avid Bioservices Announces Expiration of Hart-Scott-Rodino Waiting Period for Pending Acquisition by GHO and Ampersand
Express News | Avid Bioservices Announces Expiration of Hart-Scott-Rodino Waiting Period for Pending Acquisition by Gho and Ampersand
Avid Bioservices Insider Sold Shares Worth $1,783,032, According to a Recent SEC Filing
Avid Bioservices Insider Sold Shares Worth $278,775, According to a Recent SEC Filing
Express News | Avid Bioservices Inc: Special Meeting to Vote on Transaction Scheduled for Jan 30, 2025
Express News | Avid Bioservices Recommends Stockholders Vote for Value Maximizing Transaction
Avid Bioservices Recommends Stockholders Vote FOR Value Maximizing Transaction
Stephens Maintains Avid Bioservices(CDMO.US) With Hold Rating, Maintains Target Price $12.5
Craig-Hallum Maintains Avid Bioservices(CDMO.US) With Hold Rating
Craig-Hallum Sticks to Its Hold Rating for Avid Bioservices (CDMO)
Avid Bioservices Reports 32% Revenue Growth Ahead Of Acquisition
Avid Bioservices: Fiscal Q2 Earnings Snapshot
Avid Bioservices | 10-Q: Q2 2025 Earnings Report
Avid Bioservices Suspending Practice of Providing Fincl Guidance in Light of Proposed Transaction >CDMO
Avid Bioservices 2Q Loss/Shr 27c >CDMO
Express News | Avid Bioservices Reports Financial Results for Second Quarter Ended October 31, 2024
Press Release: Avid Bioservices Reports Financial Results for Second Quarter Ended October 31, 2024
Ascendia Pharmaceutical Solutions Launched to Meet Drug Development and Manufacturing Needs
Earnings Week Ahead: ORCL, GME, ADBE, COST, AVGO, M and More